Home/Rare Diseases/Moyamoya Disease

Cardiovascular

Moyamoya Disease

Also called Moyamoya Phenomenon, Progressive Cerebral Arteriopathy of Infancy

Moyamoya Disease is a progressive, noninflamatory cerebrovascular disease causing stenosis (narrowing) of the terminal portions of the internal carotid arteries and their major branches. In response to this narrowing, the body develops abnormal collateral vessels at the base of the brain that create the characteristic 'puff of smoke' appearance on cerebral angiography.

View active trialsMatch me to a trial

About Moyamoya Disease

Moyamoya Disease is a progressive, noninflamatory cerebrovascular disease causing stenosis (narrowing) of the terminal portions of the internal carotid arteries and their major branches. In response to this narrowing, the body develops abnormal collateral vessels at the base of the brain that create the characteristic 'puff of smoke' appearance on cerebral angiography. These collateral vessels are fragile and prone to rupture. The disease can present with ischemic symptoms (stroke, TIA) or hemorrhagic symptoms (bleeding), with ischemic presentations more common in children and hemorrhagic presentations more common in adults. Symptoms may be preceded by hyperventilation, emotional stress, or certain activities. Cognitive and behavioral changes can occur, particularly with recurrent ischemic events. The disease is often bilateral, affecting both sides of the brain, though one side may be more severely affected. Progression is variable and unpredictable, making management challenging.

Common Symptoms

  • Transient ischemic attacks (TIAs) with temporary weakness or numbness
  • Ischemic stroke causing sudden weakness, numbness, speech difficulties, or vision loss
  • Recurrent headaches
  • Seizures
  • Involuntary movements or tremors
  • Cognitive decline and memory problems

Who It Affects

Moyamoya Disease typically presents in two age groups: children aged 5-14 years and adults in their 40s-50s. It is more common in people of East Asian descent, particularly Japanese, Korean, and Chinese populations, though cases have been identified in all ethnic groups. The condition affects males and females equally. Familial cases account for approximately 10% of presentations, suggesting a genetic component.

Getting Involved in Clinical Trials

Clinical trials for Moyamoya Disease focus on optimizing surgical revascularization techniques, neuroprotection strategies, and medical management of risk factors. Research is examining the role of antiplatelet therapy, anticoagulation, and newer interventions aimed at promoting collateral vessel development and stabilization. Neuroimaging advances are improving understanding of disease progression and outcomes. Patients should consult with a neuroradiologist or neurosurgeon experienced in moyamoya disease, as specialized centers often have access to research opportunities and latest treatment protocols.

Trusted Sources

Active Clinical Trials for Moyamoya Disease

Finding trials for Moyamoya Disease...

Related Cardiovascular Conditions

Cardiovascular

Peripartum Cardiomyopathy

Peripartum cardiomyopathy is a rare form of heart failure that develops during the last month of pregnancy or within 5 m...

Cardiovascular

Hereditary Hemorrhagic Telangiectasia

Hereditary Hemorrhagic Telangiectasia is a rare genetic disorder characterized by abnormal blood vessel formation (telan...